株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

好酸球性食道炎:世界の治験動向

Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 240613
出版日 ページ情報 英文 68 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.37円で換算しております。
Back to Top
好酸球性食道炎:世界の治験動向 Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016
出版日: 2016年11月30日 ページ情報: 英文 68 Pages
概要

当レポートでは、好酸球性食道炎に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7およびE7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んでお届けします。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 主要国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米

G7諸国における治験件数:好酸球性食道炎治験件数の消化管疾患治験件数に対する比率

フェーズ(相)別治験件数: G7諸国

G7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

一定期間に採用された被験者数

スポンサーの種類別治験件数

有望なスポンサー

治験主要参加企業 - 好酸球性食道炎治療薬

有望な薬剤

最新治験ニュース:好酸球性食道炎

治験プロファイルの基本情報

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3922CTIDB

GlobalData's clinical trial report, "Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016" provides an overview of Eosinophilic Esophagitis clinical trials scenario. This report provides top line data relating to the clinical trials on Eosinophilic Esophagitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Eosinophilic Esophagitis to Gastrointestinal Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Eosinophilic Esophagitis Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Eosinophilic Esophagitis
      • Oct 13, 2016: Celgene to Present New Data on RPC4046 at UEGW and ACG Congresses
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
  • Source

List of Tables

  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Region, 2016*
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Proportion of Eosinophilic Esophagitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016*
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Eosinophilic Esophagitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Proportion of Eosinophilic Esophagitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016*
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Eosinophilic Esophagitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Eosinophilic Esophagitis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Eosinophilic Esophagitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Eosinophilic Esophagitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top